Literature DB >> 15979269

Improved survival in cancer of the colon and rectum in Sweden.

H Birgisson1, M Talbäck, U Gunnarsson, L Påhlman, B Glimelius.   

Abstract

AIMS: To analyse time-trends in survival of patients with colon and rectal cancer in Sweden. PATIENTS AND METHODS: Data including all patients diagnosed with adenocarcinoma of the colon and rectum between 1960 and 1999, from the Swedish Cancer Registry, were analysed. The observed and relative survival rates were calculated according to the Hakulinen cohort method.
RESULTS: Five-year relative survival rate for cancer of the colon improved significantly from 39.6% in 1960--1964 to 57.2% in 1995--1999 and for rectal cancer from 36.1 to 57.6%, respectively. Corresponding observed survival improved from 31.2 to 44.3% for colon cancer and from 28.4 to 45.4% for rectal cancer. The largest improvement of survival were seen during the later part of the period observed.
CONCLUSION: The survival of patients with colon and rectal cancer in Sweden continues to improve, especially in rectal cancer, which now has a 5-year observed and relative survival rate comparable to that for colon cancer. The survival improvement in rectal cancer is probably a result of the implementation of total mesorectal excision and pre-operative radiotherapy.

Entities:  

Mesh:

Year:  2005        PMID: 15979269     DOI: 10.1016/j.ejso.2005.05.002

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  39 in total

Review 1.  Surveillance of patients following surgery with curative intent for colorectal cancer.

Authors:  Steven Gan; Katherine Wilson; Paul Hollington
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

2.  Complete mesocolic excision--a marker of surgical quality?

Authors:  Aisling M Hogan; Des C Winter
Journal:  J Gastrointest Surg       Date:  2009-08-05       Impact factor: 3.452

3.  Laparoscopic right hemicolectomy with complete mesocolic excision provides acceptable perioperative outcomes but is lengthy--analysis of learning curves for a novice minimally invasive surgeon.

Authors:  George Melich; Duck Hyoun Jeong; Hyuk Hur; Seung Hyuk Baik; Julio Faria; Nam Kyu Kim; Byung Soh Min
Journal:  Can J Surg       Date:  2014-10       Impact factor: 2.089

4.  Differential effects of patient-related factors on the outcome of radiation therapy for rectal cancer.

Authors:  Ikuko Kato; Gregory Dyson; Michael Snyder; Hyeong-Reh Kim; Richard K Severson
Journal:  J Radiat Oncol       Date:  2016-01-27

5.  Initial experience of laparoscopic right hemicolectomy with complete mesocolic excision in Singapore: a case series.

Authors:  Ming Li Ho; Cheryl Chong; Shen Ann Yeo; Chee Yung Ng
Journal:  Singapore Med J       Date:  2019-01-15       Impact factor: 1.858

6.  Multidisciplinary teams in the management of rectal cancer.

Authors:  Vincent J Obias; Harry L Reynolds
Journal:  Clin Colon Rectal Surg       Date:  2007-08

Review 7.  Long-term survival of cancer patients compared to heart failure and stroke: a systematic review.

Authors:  Vasileios Askoxylakis; Christian Thieke; Sven T Pleger; Patrick Most; Judith Tanner; Katja Lindel; Hugo A Katus; Jürgen Debus; Marc Bischof
Journal:  BMC Cancer       Date:  2010-03-22       Impact factor: 4.430

8.  Intensive surveillance following curative treatment of colorectal cancer allows effective treatment of recurrence even if limited to 4 years.

Authors:  Katie Adams; Lynne Higgins; Stella Beazley; Savvas Papagrigoriadis
Journal:  Int J Colorectal Dis       Date:  2015-08-30       Impact factor: 2.571

9.  The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer.

Authors:  Helgi Birgisson; Arezo Ghanipour; Kennet Smedh; Lars Påhlman; Bengt Glimelius
Journal:  Fam Cancer       Date:  2009       Impact factor: 2.375

Review 10.  Treatment of colorectal cancer in older patients.

Authors:  Riccardo A Audisio; Demetris Papamichael
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-10-09       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.